Skip to main content

NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

immunomodulatory agent CC-11006

A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	CC-11006 CC-11006-MDS-001

immunomodulatory agent CC-11006

Search NCI's Drug Dictionary